Lilly CEO emphasizes tax and regulatory reforms, as well as drug affordability, as key priorities under the Trump administration David Ricks, CEO of Eli Lilly, stated at the Economic Club of Washington on Tuesday that the company’s policy priorities By mansi December 12, 2024